Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL, a Randomised Placebo Controlled Trial

NCT06052696 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06052696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL, a Randomised Placebo Controlled Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2024
Completion date
December 1, 2030
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv, vulvar hsil